Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014484 |
| CAS No | NA |
| Mol.F. | C40H48N10O8 |
| Mol.Wt. | 796.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014485 |
| CAS No | NA |
| Mol.F. | C40H49N9O7 |
| Mol.Wt. | 767.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014486 |
| CAS No | NA |
| Mol.F. | C24H24ClFN6O3 |
| Mol.Wt. | 498.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014487 |
| CAS No | NA |
| Mol.F. | C14H20N4O3S |
| Mol.Wt. | 324.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014488 |
| CAS No | NA |
| Mol.F. | C16H14ClFN4O |
| Mol.Wt. | 332.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014489 |
| CAS No | 96806-34-7 |
| Mol.F. | C5H10ClN3O3 |
| Mol.Wt. | 195.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014490 |
| CAS No | NA |
| Mol.F. | C12H13N3O |
| Mol.Wt. | 215.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014491 |
| CAS No | NA |
| Mol.F. | C16H13F3N4O3S |
| Mol.Wt. | 398.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014492 |
| CAS No | NA |
| Mol.F. | C19H19N3O4 |
| Mol.Wt. | 353.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014493 |
| CAS No | NA |
| Mol.F. | C22H25N3O3S |
| Mol.Wt. | 411.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014494 |
| CAS No | NA |
| Mol.F. | C19H16F6N8O2 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014495 |
| CAS No | NA |
| Mol.F. | C19H15F6N9O3 |
| Mol.Wt. | 531.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014496 |
| CAS No | NA |
| Mol.F. | C19H16F6N8O2 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014497 |
| CAS No | NA |
| Mol.F. | C22H26ClFN8O5S |
| Mol.Wt. | 569.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014498 |
| CAS No | NA |
| Mol.F. | C25H29N7O3 |
| Mol.Wt. | 475.6 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014500 |
| CAS No | NA |
| Mol.F. | C16H24N2O5 |
| Mol.Wt. | 324.4 g/mol |
| INV STATUS | In Stock |